Abiopharma

Castle Biosciences - New Analysis of 13,560 Patients DemonstratesDecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference

New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference

Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production

Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma

QuidelOrtho Corporation - Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

ResMed Inc. Daily Stock Update